Fortitude Family Office’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.15K | Buy |
223
+16
| +8% | +$370 | ﹤0.01% | 778 |
|
|
2025
Q1 | $5.59K | Hold |
207
| – | – | ﹤0.01% | 698 |
|
|
2024
Q4 | $11.1K | Hold |
207
| – | – | ﹤0.01% | 604 |
|
|
2024
Q3 | $9.4K | Hold |
207
| – | – | ﹤0.01% | 590 |
|
|
2024
Q2 | $8.67K | Hold |
207
| – | – | ﹤0.01% | 441 |
|
|
2024
Q1 | $7.79K | Sell |
207
-30
| -13% | -$1.13K | 0.01% | 456 |
|
|
2023
Q4 | $2.54K | Buy |
+237
| New | +$2.54K | ﹤0.01% | 833 |
|